Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 17/20 | 0.66 |
| ▸ | MMP13 | P45452 | 15/20 | 0.48 |
| ▸ | MMP9 | P14780 | 11/20 | 0.48 |
| ▸ | MMP2 | P08253 | 10/20 | 0.48 |
| ▸ | MMP14 | P50281 | 6/20 | 0.48 |
| ▸ | MMP3 | P08254 | 6/20 | 0.48 |
| ▸ | MMP8 | P22894 | 5/20 | 0.48 |
| ▸ | ADAM17 | P78536 | 7/20 | 0.48 |
| ▸ | ADAMTS4 | O75173 | 2/20 | 0.48 |
| ▸ | ADAMTS5 | Q9UNA0 | 2/20 | 0.48 |
| ▸ | MMP7 | P09237 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7301736 | 0.89 | MMP1 (0.70) | MMP1MMP13MMP9MMP2MMP14 | |
| SCHEMBL7312641 | 0.89 | MMP1 (0.52) | MMP1MMP13MMP9MMP2MMP14 | |
| SCHEMBL7303077 | 0.86 | MMP1 (0.72) | MMP1MMP13MMP9MMP2MMP14 | |
| SCHEMBL7311291 | 0.84 | MMP1 (0.64) | MMP1MMP13MMP9MMP2MMP14 | |
| SCHEMBL7299271 | 0.84 | MMP1 (0.66) | MMP1MMP13MMP9MMP2MMP14 | |
| SCHEMBL7311958 | 0.83 | MMP1 (0.63) | MMP1MMP13MMP9MMP2MMP14 | |
| SCHEMBL7309090 | 0.83 | MMP1 (0.80) | MMP1MMP13MMP9MMP2MMP14 | |
| SCHEMBL7301387 | 0.82 | MMP1 (0.79) | MMP1MMP13MMP9MMP2MMP14 | |
| SCHEMBL7308211 | 0.80 | MMP1 (0.76) | MMP1MMP13MMP9MMP2MMP14 | |
| SCHEMBL7307897 | 0.80 | MMP1 (1.00) | MMP1MMP13MMP9MMP2MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0780386-B1 | Matrix metalloprotease inhibitors | HOFFMANN LA ROCHE (CH) | 2002-10-02 | — | — | EP | disclosed |
| EP-0780386-A1 | Matrix metalloprotease inhibitors | F. HOFFMANN-LA ROCHE AG (CH) | 1997-06-25 | — | — | EP | disclosed |